novo nordisk eli lilly - Search News

News

Eli Lilly's Zepbound Defeats Novo Nordisk's Wegovy

Reuters on MSN · 13h

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial. The data is the first head-to-head trial comparing the wildly popular medicines,

Quartz on MSN · 9h

Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s drug came out on top.

Yahoo Finance · 10h

Novo Nordisk Tumbles as Lilly's Zepbound Shows Greater Weight Loss in Trial

Novo Nordisk shares dropped 5% in early trading on Monday after Eli Lilly released new trial data showing its weight loss drug, Zepbound, delivered stronger results than Wegovy. I

Eli Lilly shares fall as competitor Novo notches coverage win for obesity drug

Eli Lilly shares dropped Thursday as Novo Nordisk notched a coverage win for its obesity drug, a sign of the competition in ...

5don MSN

Novo Nordisk Gains as CFO Touts Wegovy’s Rebound Potential

Novo Nordisk A/S shares gained on expectations that competition for its blockbuster obesity shot Wegovy will subside later ...

4don MSN

Down Nearly 20%: Should You Buy the Dip on Eli Lilly?

Sales are booming for Lilly's tirzepatide products, Mounjaro and Zepbound. The company's market share for incretin analogs ...

5don MSN

Novo Nordisk's CFO Sceptical Trump Executive Order on Drug Manufacturing Can Cut Timelines

LONDON/COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results